Skip to Content

Label Changes for:

Zometa (zoledronic acid for injection)

February 2011

Changes have been made to the ADVERSE REACTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – February 2011



Postmarketing Experience
  • ...pyrexia, asthenia, fatigue, or malaise persisting for greater than 30 days has been observed